We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
326
DELISTED
Select Medical
SEM
| $20.8M | 0.03% |
2,916,340
+269
| +0% | +$1.87K |
|
|
RPXC
327
DELISTED
RPX Corporation
RPXC
| $20.4M | 0.03% |
1,885,724
-8,407
| -0.4% | -$88.3K |
|
|
TXNM
328
TXNM Energy Inc
TXNM
$6.47B
| $20.2M | 0.03% |
587,916
+24,604
| +4% | +$798K |
|
|
HSII
329
DELISTED
Heidrick & Struggles
HSII
| $20M | 0.03% |
827,448
+133,746
| +19% | +$2.81M |
|
330
Jones Lang LaSalle
JLL
$15.1B
| $19.9M | 0.03% |
+197,286
| New | +$19.8M |
|
331
TETRA Technologies
TTI
$1.23B
| $19.9M | 0.03% |
3,968,644
+1,330,604
| +50% | +$7.2M |
|
|
SFR
332
DELISTED
Starwood Waypoint Homes
SFR
| $19.8M | 0.03% |
686,010
+170,990
| +33% | +$4.97M |
|
|
HBI
333
DELISTED
Hanesbrands
HBI
| $19.6M | 0.03% |
909,809
-22,103
| -2% | -$528K |
|
334
Accuray
ARAY
$28.4M
| $19.3M | 0.03% |
4,198,090
-373,300
| -8% | -$1.94M |
|
|
GLDD
335
DELISTED
Great Lakes Dredge & Dock
GLDD
| $19.1M | 0.03% |
4,559,006
-1,148,766
| -20% | -$4.66M |
|
336
Scholastic
SCHL
$796M
| $18.8M | 0.02% |
395,030
+157,736
| +66% | +$6.7M |
|
|
MPSX
337
DELISTED
Multi Packaging Solutions Intl.
MPSX
| $18.6M | 0.02% |
1,307,104
-8,197
| -0.6% | -$114K |
|
|
GPT
338
DELISTED
Gramercy Property Trust
GPT
| $18.6M | 0.02% |
674,805
+66,517
| +11% | +$1.77M |
|
|
EXAR
339
DELISTED
Exar Corporation
EXAR
| $18.3M | 0.02% |
1,699,310
-1,063,610
| -38% | -$10.3M |
|
340
FreightCar America
RAIL
$275M
| $18.2M | 0.02% |
1,221,984
-113,227
| -8% | -$1.62M |
|
341
Stagwell
STGW
$1.84B
| $18.2M | 0.02% |
2,781,142
+1,464,102
| +111% | +$10.8M |
|
342
National Bank Holdings
NBHC
$1.93B
| $18.2M | 0.02% |
570,679
-253,420
| -31% | -$6.8M |
|
|
VDTH
343
DELISTED
Videocon d2h Limited
VDTH
| $18M | 0.02% |
2,170,163
-460,048
| -17% | -$4.06M |
|
|
CLGX
344
DELISTED
Corelogic, Inc.
CLGX
| $18M | 0.02% |
488,932
+212,946
| +77% | +$8.24M |
|
|
INVX
345
Innovex International
INVX
$1.87B
| $17.8M | 0.02% |
297,191
+1,034
| +0.3% | +$57.5K |
|
|
STBZ
346
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $17.6M | 0.02% |
655,420
-214,270
| -25% | -$5.22M |
|
|
HI
347
DELISTED
Hillenbrand
HI
| $17.3M | 0.02% |
451,774
-1,202
| -0.3% | -$40.6K |
|
348
Central Pacific Financial
CPF
$997M
| $17.3M | 0.02% |
549,835
-66,300
| -11% | -$1.87M |
|
|
IPCC
349
DELISTED
Infinity Property & Casualty C
IPCC
| $17.1M | 0.02% |
194,144
+323
| +0.2% | +$27.4K |
|
|
FTD
350
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $16.8M | 0.02% |
706,537
-374
| -0.1% | -$8.26K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.